Biological Information
Background Information:
Adrenoreceptors belong to the superfamily of G protein-coupled seven transmembrane proteins. G-protein-coupled receptors constitute one of the major signal transduction systems in eukaryotic cells. Coding sequences for these receptors, in those regions believed to contribute to the agonist-antagonist binding site, are strongly conserved across mammalian species. Adrenoreceptors are found in most peripheral tissue and within the central nervous system.
Family:
GPCR
Sub Family:
Adrenoceptor
Class:
Class A
Organism:
Rat
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Binding
Detection Method:
Radiometry
Measured Response:
Scintillation
Testing Information
Procedure Summary:
Whole brain (except cerebellum) of male Wistar derived rats weighing 175 ± 25 g is used to prepare adrenergic a1 receptors in modified Tris-HCl buffer pH 7.4. A 5 mg‡ aliquot is incubated with 0.25 nM [³H]Prazosin for 30 minutes at 25℃. Non-specific binding is estimated in the presence of 0.1 µM prazosin. Membranes are filtered and washed 3 times and the filters are counted to determine [³H]Prazosin specifically bound. Compounds are screened at 10 µM.
Note: ‡Membrane protein may change from lot to lot, the concentration used will be adjusted if necessary.
Ligand:
[³H] Prazosin
Ligand Kd (nM):
0.29
Ligand Concentration:
0.25 nM
Non Specific:
0.1 µM Prazosin
Incubation:
30 min at 25°C
Control Inhibitor:
Prazosin
Criteria For Significance:
≥ 50% of max stimulation or inhibition
Test Concentration / Dose:
Suggested concentration for initial testing is 10 uM
Test Sample Requirements:
Minimum for 1) Screen: 25 μl of 10 mM stock -OR- 1 mg (pre-weighed). 2) Dose Response: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed).
Minimum Order Quantity:
2
Turnaround Time
Standard:
15 Business Days
Reference Compound Data
Clinical Relevance
Therapeutic Area:
Cardiovascular
Adverse / Beneficial Action:
Adrenergic 1 receptor antagonism may result in hypotension as well as orthostatic hypotension and may be useful in the treatment of benign prostatic hyperplasia.
Additional Information
Brand:
LeadHunter
Testing Location:
Taiwan - Taipei